二甲基丙二酸减缓琥珀酸蓄积并保护失血性休克猪模型的心功能
该研究在失血性休克猪模型中验证二甲基丙二酸(DMM)的治疗作用:将约克夏猪放血至平均动脉压(MAP)45 mmHg并维持休克30分钟,随后用乳酸林格液复苏至MAP 60 mmHg以上;DMM组(n=6)接受10 mg/kg DMM,对照组(n=6)接受假注射。主要终点琥珀酸水平:对照组从基线升至复苏20分钟时,DMM组保持不变;DMM组维持MAP>60 mmHg所需静脉液体量更少(450.0 vs 229.0 mL,p=0.01),复苏20分钟和40分钟时肺动脉楔压更高,复苏期间心输出量及心指数恢复更好,对照组无改善。作者认为DMM可能具有失血性休克治疗潜力。
要点
- 失血性休克猪模型中,DMM 10 mg/kg组维持MAP>60 mmHg所需静脉液体量为229.0 mL,对照组为450.0 mL(p=0.01)。
- 对照组琥珀酸水平从基线升至复苏20分钟时,DMM组琥珀酸水平保持不变。
- DMM组复苏20分钟和40分钟时肺动脉楔压高于对照组,复苏期间心输出量及心指数恢复更好,对照组无改善。
- 两组乳酸水平相似;DMM可能使离子钙水平升高。
- 作者认为DMM可能具有失血性休克治疗潜力,可减缓琥珀酸蓄积并保护心脏充盈压和功能。
适用人群与场景
- 约克夏猪失血性休克模型:颈动脉置入5-Fr导管,放置Swan-Ganz导管和股动脉测压管后放血至MAP 45 mmHg,休克状态维持30分钟后用乳酸林格液复苏至MAP 60 mmHg以上并全程维持。
诊断标准与关键阈值
- 失血性休克模型标准:放血至平均动脉压(MAP)45 mmHg。
- 复苏目标:用乳酸林格液将MAP复苏至60 mmHg,并在整个复苏期间维持MAP高于60 mmHg。
处置流程与药物剂量
- DMM组给予10 mg/kg二甲基丙二酸(DMM);对照组给予假注射。
- 休克30分钟后用乳酸林格液复苏至MAP 60 mmHg,并维持MAP高于60 mmHg。
研究设计与关键结果
- 研究类型:猪失血性休克模型;DMM组n=6,对照组n=6;主要终点为琥珀酸水平。
- 琥珀酸水平:对照组从基线升至复苏20分钟时升高,DMM组保持不变。
- 维持MAP>60 mmHg所需静脉液体量:DMM组229.0 mL vs 对照组450.0 mL(p=0.01)。
- DMM组复苏20分钟和40分钟时肺动脉楔压高于对照组。
- DMM组复苏期间心输出量和心指数恢复更好,对照组无改善。
- 两组乳酸水平相似;DMM可能使离子钙水平升高。
证据类型、等级与局限
- 证据类型:动物实验(猪失血性休克模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在失血性休克猪模型中,DMM 10 mg/kg减缓琥珀酸蓄积、减少维持MAP>60 mmHg所需液体量并改善复苏期间心功能;作者认为DMM可能具有失血性休克治疗潜力。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Succinate (SI) is a citric acid cycle metabolite that accumulates in tissues during hemorrhagic shock (HS) due to electron transport chain uncoupling. Dimethyl malonate (DMM) is a competitive inhibitor of SI dehydrogenase, which has been shown to reduce SI accumulation and protect against reperfusion injury. Whether DMM can be therapeutic after severe HS is unknown. We hypothesized that DMM would prevent SI buildup during resuscitation (RES) in a swine model of HS, leading to better physiological recovery after RES.
METHODS: The carotid arteries of Yorkshire pigs were cannulated with a 5-Fr catheter. After placement of a Swan-Ganz catheter and femoral arterial line, the carotid catheters were opened and the animals were exsanguinated to a mean arterial pressure (MAP) of 45 mm. After 30 minutes in the shock state, the animals were resuscitated to a MAP of 60 mm using lactated ringers. A MAP above 60 mm was maintained throughout RES. One group received 10 mg/kg of DMM (n = 6), while the control received sham injections (n = 6). The primary end-point was SI levels. Secondary end-points included cardiac function and lactate.
RESULTS: Succinate levels increased from baseline to the 20-minute RES point in control, while the DMM cohort remained unchanged. The DMM group required less intravenous fluid to maintain a MAP above 60 (450.0 vs. 229.0 mL; p = 0.01). The DMM group had higher pulmonary capillary wedge pressure at the 20-minute and 40-minute RES points. The DMM group had better recovery of cardiac output and index during RES, while the control had no improvement. While lactate levels were similar, DMM may lead to increased ionized calcium levels.
DISCUSSION: Dimethyl malonate slows SI accumulation during HS and helps preserve cardiac filling pressures and function during RES. In addition, DMM may protect against depletion of ionized calcium. Dimethyl malonate may have therapeutic potential during HS.
参考来源
- Taghavi S, Abdullah S, Toraih E, et al. Dimethyl malonate slows succinate accumulation and preserves cardiac function in a swine model of hemorrhagic shock. J Trauma Acute Care Surg. 2022. PMID: 35234713. doi:10.1097/TA.0000000000003593
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。